semaglutide weight loss mechanism action How Does Work to Lose Weight? Semaglutide vs Tirzepatide: Dosing, Results,

-Can help the body convert fat into energy -May help reduce cravings -Can help support immune system Low Dose Naltrexone (LDN) Possible benefits of LDN include: Reducing inflammation may make weight loss easier in certain patients

| Category | Zepbound | Mounjaro | |-----------------------------------|------------------------------------------------|------------------------------------------------| | FDA Approval Indication | Obesity and overweight management (with comorbidities) | Type 2 diabetes management | | Year of FDA Approval | 2023 | 2022 | | Active Ingredient | Tirzepatide | Tirzepatide | | Dose Range | 2.5 mg to 15 mg once weekly | 2.5 mg to 15 mg once weekly | | Primary Clinical Purpose | Weight loss | Blood sugar control | | GLP-1/GIP Activity | Dual agonist (GLP-1 + GIP) | Dual agonist (GLP-1 + GIP) | | Average Weight Loss (in trials) | Up to 22.5% of body weight in SURMOUNT-1 study | Up to 15% of body weight in SURPASS studies | | Insulin Sensitivity Impact | Improves insulin sensitivity in patients with obesity | Improves insulin sensitivity in type 2 diabetes patients | | Delivery Method | Single-use auto-injector pen, subcutaneous injection | Single-use auto-injector pen, subcutaneous injection | | Dosing Frequency | Once weekly | Once weekly | | Manufacturer | Eli Lilly | Eli Lilly | | Common Side Effects | Nausea, vomiting, diarrhea, constipation, decreased appetite | Nausea, vomiting, diarrhea, constipation, decreased appetite | | Insurance Coverage | Variable

Each batch is quality-tested and made in FDA-regulated U.S

A dosage of 0.75 mg of dulaglutide was highly effective in this clinical case

have investigated the apparent selectivity of FOXO4-DRI peptide in regard to specifically targeting aged cells for apoptosis